Data obtained using HDAC11-null mice and MPN patient samples treated with selective HDAC11 inhibitors suggest that HDAC11 contributes to the neoplastic nature of MPN cells but not normal hematopoiesis (50). The gene discussed is HDAC11; the disease is myeloproliferative neoplasm.